Fulgent Genetics, Inc. (FLGT)
19.61
-0.34
(-1.70%)
USD |
NASDAQ |
Aug 28, 16:00
19.63
+0.02
(+0.10%)
After-Hours: 20:00
Fulgent Genetics EPS Diluted (Quarterly) : -1.054 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.054 |
| March 31, 2026 | -0.8039 |
| December 31, 2025 | -0.7559 |
| September 30, 2025 | -0.2149 |
| June 30, 2025 | -0.6206 |
| March 31, 2025 | -0.374 |
| December 31, 2024 | -0.1921 |
| September 30, 2024 | -0.4816 |
| June 30, 2024 | -0.2894 |
| March 31, 2024 | -0.4522 |
| December 31, 2023 | -4.304 |
| September 30, 2023 | -0.4367 |
| June 30, 2023 | -0.3766 |
| March 31, 2023 | -0.5194 |
| December 31, 2022 | -0.8045 |
| September 30, 2022 | 0.0557 |
| June 30, 2022 | 0.3699 |
| March 31, 2022 | 4.929 |
| December 31, 2021 | 3.344 |
| September 30, 2021 | 3.931 |
| June 30, 2021 | 2.589 |
| March 31, 2021 | 6.522 |
| December 31, 2020 | 6.221 |
| Date | Value |
|---|---|
| September 30, 2020 | 1.981 |
| June 30, 2020 | 0.1449 |
| March 31, 2020 | -0.0907 |
| December 31, 2019 | -0.0148 |
| September 30, 2019 | 0.0751 |
| June 30, 2019 | 0.0174 |
| March 31, 2019 | -0.1047 |
| December 31, 2018 | -0.1133 |
| September 30, 2018 | -0.033 |
| June 30, 2018 | -0.0585 |
| March 31, 2018 | -0.1069 |
| December 31, 2017 | -0.10 |
| September 30, 2017 | -0.06 |
| June 30, 2017 | -0.0014 |
| March 31, 2017 | 0.01 |
| December 31, 2016 | 0.05 |
| September 30, 2016 | -0.44 |
| June 30, 2016 | -0.2541 |
| March 31, 2016 | -0.045 |
| December 31, 2015 | -0.4151 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 2.848 |
| Labcorp Holdings, Inc. | 3.643 |
| OPKO Health, Inc. | -0.0111 |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 0.0171 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.72M |
| Revenue (Quarterly) | 85.39M |
| Total Expenses (Quarterly) | 114.92M |
| Enterprise Value | 286.51M |
| Gross Profit Margin (Quarterly) | 27.02% |
| Profit Margin (Quarterly) | -34.80% |
| Earnings Yield | -14.43% |
| Normalized Earnings Yield | -13.77 |